$VCYT news
The latest VCYT stock news: headlines, filings, AI summaries and sentiment for $VCYT, updated around the clock.
- Castle Biosciences Reports Q3 2026 Revenue Growth and Raises Full-Year Guidance
- Veracyte Projects 2027 Growth Targets Amid Q3 Revenue Increase
- Veracyte Shares Drop 56% Following Third-Quarter Results and Revised 2026 Revenue Outlook
- Veracyte Reports Q3 2026 Revenue Growth Driven by Afirma and Decipher Prostate
- Veracyte Shares Plunge Following Lowered Full-Year Guidance and Analyst Downgrade
- VERACYTE, INC. - 10-Q Filing
- VERACYTE, INC. - 8-K Filing
- ARK Invest Adjusts Portfolio: Adds AI, Biotech Exposure While Reducing Holdings in HOOD, TER
- VERACYTE, INC. - 8-K Filing
- Stocks Making Significant Moves Midday: IES Holdings, GoDaddy, and Others
- VERACYTE, INC. - 8-K Filing
- Insider Sale at Veracyte Following Significant Stock Rally
- $197,000 Insider Sale by Veracyte Director Karin Eastham Amidst a 120% Stock Rally
- Veracyte Stock Surges After Strong First-Quarter Earnings and Growth Outlook
- Veracyte Reports Q1 2026 Earnings with Strong Revenue and Volume Growth